Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Development of a diagnostic biomarker panel for early-stage lung adenocarcinoma using serum-derived small RNAs.

Created on 17 Nov 2026

Authors

Daisuke Ueda, Ryou-U Takahashi, Yasuhiro Tsutani, Yukie Nishiyama, Yumiko Koi, Yuta Ibuki, Yoshihiro Miyata, Tomoyuki Akita, Junko Tanaka, Morihito Okada, Hidetoshi Tahara

Published in

PloS one. Volume 21. Issue 11. Pages e0362879. Epub Nov 16, 2026.

Abstract

Circulating small RNAs, such as microRNAs (miRNAs) and transfer RNA fragments (tRFs), reportedly reflect the physiological and pathological conditions in various diseases. Herein, we aimed to identify circulating small RNAs for the early diagnosis of lung adenocarcinoma.
This study included 40 healthy controls and 43 patients with lung adenocarcinoma. We analyzed their serum using small RNA sequencing and identified differentially expressed small RNAs between healthy controls and patients with lung adenocarcinoma. We verified the expression profiles of these small RNAs in 29 patients with lung adenocarcinoma and 27 healthy controls. Finally, we evaluated our current results by performing machine learning-based analysis.
The expressions of two mature miRNAs (miR-193a-5p, miR-423-5p), one miRNA isoform (isomiR) (miR-423-5p(21nt)), and two tRFs (tRF-Gly(CCC)(29nt), tRF-Gly(CCC)(30nt)) were significantly elevated in patients with lung adenocarcinoma than in healthy controls. Moreover, the expressions of one miRNA (miR-20a-5p) and five tRFs (tRF-iMet(CAT)(31nt), tRF-Lys(CTT), tRF-iMet(CAT)(30nt), tRF-iMet(CAT)(29nt), tRF-Val(AAC)) were significantly decreased in patients with lung adenocarcinoma than in healthy controls (area under the curve [AUC] values = 0.71 to 0.85, respectively). Furthermore, a combination of six small RNAs (miR-193a-5p, miR-423-5p(21nt), miR-20a-5p, tRF-Gly(CCC)(29nt), tRF-iMet(CAT)(29nt), and tRF-Val(AAC)) was useful for developing a biomarker panel for the early diagnosis of lung adenocarcinoma. Discovery screening revealed that the panel demonstrated a sensitivity of 0.954 and a specificity of 0.925 (AUC = 0.974), whereas the validation data demonstrated a sensitivity of 0.690 and a specificity of 0.926 (AUC = 0.924).
Serum-derived small RNAs are associated with the status of patients with lung adenocarcinoma, and evaluating small RNAs in serum is a promising non-invasive approach for diagnosing lung adenocarcinoma at an early stage.

PMID:
43038279
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement